Class, Inc. | |
535 Dock St Ste 104, Tacoma, WA 98402-4629 | |
(253) 874-9300 | |
(206) 374-2533 |
Full Name | Class, Inc. |
---|---|
Type | Facility |
Speciality | Speech-language Pathologist |
Location | 535 Dock St Ste 104, Tacoma, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245280890 | NPI | - | NPPES |
7101736 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | LL00001984 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Class, Inc. 23224 Landers Rd Sw, Vashon, WA 98070-6840 Ph: (253) 874-9300 | Class, Inc. 535 Dock St Ste 104, Tacoma, WA 98402-4629 Ph: (253) 874-9300 |
News Archive
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free' and ‘denicotinized,' may be more effective for quitting than FDA-approved therapies.
A research team from the Massachusetts Institute of Technology (MIT)-Harvard Center for Nanotechnology Excellence has custom-designed nanoparticles that can deliver the anticancer drug cisplatin specifically to prostate cancer cells.
Hyperoxia, as well as hypoxia, early after hospital admission is associated with poor outcomes and mortality in patients with traumatic brain injury, report researchers in the Archives of Surgery.
High street stores must do more to phase out chemicals which may adversely affect human health, Friends of the Earth said today. The call coincides with a new survey by the environmental campaign group showing some stores are still not taking effective action to remove risky chemicals from their products.
The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan.
› Verified 4 days ago
Andrea Lynn Rottier, LL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4301 S Pine St, Ste 219, Tacoma, WA 98409 Phone: 253-476-6550 | |
Janet Kobayashi-hobson, CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Christine L Camp, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 E 44th St, Tacoma, WA 98404 Phone: 253-571-2908 | |
Ann S Lewis, B.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 S 76th St, Tacoma, WA 98408 Phone: 253-571-4579 | |
Angela Curtis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-7919 | |
Porsche Maneice, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 242 St Helens Ave, Tacoma, WA 98402 Phone: 253-627-3833 | |
Peggy Lesniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 S Union Ave Ste A100, Tacoma, WA 98405 Phone: 253-383-2423 |